OncoCyte Corporation

NASDAQ:OCX

3.33 (USD) • At close July 12, 2024
Bedrijfsnaam OncoCyte Corporation
Symbool OCX
Munteenheid USD
Prijs 3.33
Beurswaarde 44,504,118
Dividendpercentage 0%
52-weken bereik 2.08 - 4.64
Industrie Biotechnology
Sector Healthcare
CEO Mr. Joshua Riggs
Website https://oncocyte.com

An error occurred while fetching data.

Over OncoCyte Corporation

OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing,

Vergelijkbare Aandelen

Shattuck Labs, Inc. logo

Shattuck Labs, Inc.

STTK

4.19 USD

MediciNova, Inc. logo

MediciNova, Inc.

MNOV

1.439 USD

MDxHealth SA logo

MDxHealth SA

MDXH

2.375 USD

Jasper Therapeutics, Inc. logo

Jasper Therapeutics, Inc.

JSPR

19.1 USD

Werewolf Therapeutics, Inc. logo

Werewolf Therapeutics, Inc.

HOWL

2.69 USD

Olema Pharmaceuticals, Inc. logo

Olema Pharmaceuticals, Inc.

OLMA

12.3 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)